Regulatory Cells, Cytokine Pattern and Clinical Risk Factors for Asthma in Infants and Young Children with Recurrent Wheeze by Borrego, LM et al.
ORIGINAL ARTICLE
Regulatory cells, cytokine pattern and clinical risk factors for asthma in
infants and young children with recurrent wheeze
L. M. Borrego, M. J. Arrozw, P. Videiraw, C. Martinsw, H. Guimara˜esw, G. Nunesw, A. L. Papoilaz and H. Trindadew
Servic¸o de Imunoalergologia, Centro Hospitalar Lisboa Central – Hospital de Dona Estefaˆnia, Rua Jacinta Marto, Lisboa, Portugal, wDepartamento de Imunologia, da
Faculdade de Cieˆncias Me´dicas, da Universidade Nova de Lisboa, Campo dos Ma´rtires da Pa´tria, Lisboa, Portugal and zDepartamento de Bioestatı´stica, da Faculdade





Dr Luis Miguel Borrego, Servic¸o de
Imunoalergologia, Centro Hospitalar
Lisboa Central – Hospital de Dona
Estefania, Rua Jacinta Marto, 1169-045
Lisboa, Portugal.
E-mail: miguel.borrego@sapo.pt
Cite this as: L. M. Borrego, M. J. Arroz,
P. Videira, C. Martins, H. Guimara˜es,
G. Nunes, A. L. Papoila and H. Trindade,
Clinical & Experimental Allergy, 2009
(39) 1160–1169.
Summary
Background Several risk factors for asthma have been identified in infants and young children
with recurrent wheeze. However, published literature has reported contradictory findings
regarding the underlying immunological mechanisms.
Objectives This study was designed to assess and compare the immunological status during the
first 2 years in steroid-naı¨ve young children withX three episodes of physician-confirmed
wheeze (n= 50), with and without clinical risk factors for developing subsequent asthma (i.e.
parental asthma or a personal history of eczema and/or two of the following: wheezing
without colds, a personal history of allergic rhinitis and peripheral blood eosinophilia44%),
with age-matched healthy controls (n= 30).
Methods Peripheral blood CD41CD251 and CD41CD25high T cells and their cytotoxic
T-lymphocyte-associated antigen-4 (CTLA-4), GITR and Foxp3 expression were analysed by
flow cytometry. Cytokine (IFN-g, TGF-b and IL-10), CTLA-4 and Foxp3 mRNA expression
were evaluated (real-time PCR) after peripheral blood mononuclear cell stimulation with
phorbol 12-myristate 13-acetate (PMA) (24 h) and house dust mite (HDM) extracts (7th day).
Results Flow cytometry results showed a significant reduction in the absolute number of
CD41CD25high and the absolute and percentage numbers of CD41CD251CTLA-41 in wheezy
children compared with healthy controls. Wheezy children at a high risk of developing
asthma had a significantly lower absolute number of CD41CD251 (P= 0.01) and
CD41CD25high (P= 0.04), compared with those at a low risk. After PMA stimulation, CTLA-4
(P= 0.03) and Foxp3 (P= 0.02) expression was diminished in wheezy children compared with
the healthy children. After HDM stimulation, CTLA-4 (P= 0.03) and IFN-g (P= 0.04)
expression was diminished in wheezy children compared with healthy children. High-risk
children had lower expression of IFN-g (P= 0.03) compared with low-risk and healthy
children and lower expression of CTLA-4 (P= 0.01) compared with healthy children.
Conclusions Although our findings suggest that some immunological parameters are impaired
in children with recurrent wheeze, particularly with a high risk for asthma, further studies are
needed in order to assess their potential as surrogate predictor factors for asthma in early life.
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Introduction
Recurrent wheeze is a common symptom during infancy
and early childhood [1, 2]. Although the majority of
children will outgrow their symptoms, some go on to
develop asthma [3, 4]. A clinical index devised by Castro-
Rodriguez et al. [5] considers young children with recur-
rent wheezing in the first 3 years of life to be at a high risk
of developing asthma if there is a parental history of
asthma or a personal history of eczema, or if two of the
following are present: a personal history of allergic
rhinitis (AR), wheezing without colds and/or peripheral
blood eosinophilia 44%. Allergic asthma is a chronic
inflammatory disorder characterized by a T-helper type 2
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(Th2) immune response (e.g. IL-4, IL-5, IL-10 and IL-13)
[6]. Moreover, it has been suggested by some studies that
decreased IFN-g levels are associated with atopic diseases
[7–10]. The increase of both Th2-associated allergic dis-
eases and Th1 (e.g. IFN-g and TNF-a)-associated auto-
immune diseases has prompted the hypothesis that these
conditions might result from a functional or a quantitative
deficiency of regulatory T cells (Treg) that control Th1 and
Th2 immune responses [11–13]. CD41CD251 Treg cells
constitute 5–10% of the total CD41 T cells. These cells can
be generated in the thymus or in the periphery and reside
in blood and other lymphoid tissues [11–14]. They
have the ability to inhibit cytokine production and the
proliferation of CD41CD25 effector T cells in a contact-
dependent fashion [15–16]. TGF-b1 and cytotoxic
T-lymphocyte-associated antigen-4 (CTLA-4) appear to
be essential for their suppressive activity [17–21]. Acti-
vated and regulatory CD41 T cells might have overlapping
expressions of CD25 and hence it has been suggested that
selection of the CD41CD25high subset of CD41CD251may
minimize this contaminating effect. CD41CD25high repre-
sents 2% of the total CD41 T cells and has been considered
to be the truly regulatory population, expressing the
forkhead winged helix transcription factor Foxp 3
[22–26].
The primary aim of this study was to assess whether the
population of regulatory cells was reduced during the first
2 years of life in recurrently wheezy children with a high
risk of developing subsequent asthma [5] when compared
with age-matched ‘low-risk’ wheezing children and
healthy controls. For this purpose, Treg were studied using
flow cytometry. The secondary aim was to evaluate
whether recurrently wheezy children with a high risk of
developing asthma have a different cytokine pattern,
when compared with the two subgroups of children
(low risk for asthma and healthy). In order to evaluate
mRNA expression for cytokines, CTLA-4 and Foxp3,




Infants and young children (n= 50) aged between 8 and 20
months, with recurrent wheeze (defined asX3 episodes of
medically diagnosed wheeze) but before receiving any
inhaled corticosteroids or anti-leukotrienes, were re-
cruited from the out-patient clinic in Hospital Dona
Estefania, Lisbon (September 2005 to September 2007).
They were stratified as having a high or a low risk of
developing asthma according to the clinical index devel-
oped by Castro-Rodriguez et al. [5]. According to their
classification, high-risk children had a parental history of
asthma or a personal history of eczema, and/or two of the
following: a personal history of AR, wheezing without
colds and/or peripheral blood eosinophilia 44%. Age-
matched healthy children (n= 30) without any prior
history of lower respiratory illness or wheeze, a personal
history of allergic disorders (food allergy, eczema, rhinitis)
or parental asthma were recruited from local medical
clinics and from those attending routine screening ap-
pointments at the Ear, Nose and Throat (ENT) Department
within the same hospital. All children were born with 37
or more completed gestational weeks with birth weight
410th percentile. Children with cardiac, metabolic, neu-
rological or gastrointestinal diseases and upper airway
pathology were excluded from the study. The Ethics
Committee approved the study and parents of participat-
ing children gave informed written consent.
Flow cytometric analysis
Peripheral blood was analysed by four-colour Flow Cyto-
metry (BD FACSCalibur, BD Biosciences, San Jose, CA,
USA). To determine T cell subsets and evaluate CTLA-4
and GITR expression in CD41CD251 T cells, 100 mL
aliquots of whole blood were stained with mouse anti-
human monoclonal antibodies (mAbs) conjugated with
fluorescent dyes: anti-CD3-FITC, anti-CD8-PE, anti-CD4-
PerCP Cy5.5 (BD Biosciences), anti-CTLA-4-FITC, anti-
GITR/TNFRSF18-APC (RD, Minneapolis, MN, USA) and
anti-CD25-PE (Immunostep, Salamanca, Spain). The in-
cubation period lasted for 15min in the dark at room
temperature. Each sample was lysed with 2mL of BD FACS
Lysing Solution (BD Biosciences) for 10min, and then
washed with 2mL of BD FACS Flow (BD Biosciences).
Foxp3 expression in CD41 CD251 Tcells was studied
using the Human Treg staining Kit (eBioscience, San
Diego, CA, USA), which included anti-CD4-FITC, anti-
Foxp3-PE, anti-CD25-APC and IgG2a PE as an isotype
control. Intracellular staining for Foxp3 was performed
according to the manufacturer’s instructions. Cell Quest
3.3TM (BD Biosciences) software was used for both acqui-
sition and analysis. A combined Boolean gating for
lymphocytes (SSC/FSC) and T helper lymphocytes
(CD4high/SSC) was used. At least 20000 CD41 T cells were
acquired in order to obtain enough CD41 T regulatory
cells for accurate evaluation. CD41 CD25high T cells were
defined as CD41 T cells with a fluorescence intensity for
CD25 of 41102 on a logarithmic scale, which appeared
as a cluster above the population containing
CD41CD25low and CD41CD25, according to Baecher-
Allan et al. [22, 27]. CTLA-4 and GITR expressions were
determined in CD41CD251 T cells. The Foxp3 expression
was determined in both CD41 and CD41 T cells with CD25
expression. Results were presented as a percentage of total
lymphocytes and as absolute cell counts (cells/mL), which
were obtained using a double platform.
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Cell culture
Peripheral blood mononuclear cells (PBMC) were isolated
from heparinized blood samples using the Ficoll gradient
centrifugation, for 20min at 1200 g (LymphoprepTM,
AXIS-SHIELD PoC AS, Oslo, Norway), then washed twice
in RPMI-1640 medium with 25mM HEPES buffer solution,
and re-suspended at 1106 cells/mL in RPMI-1640 med-
ium supplemented with 0.1mM non-essential amino acids,
2mM L-glutamine, 1mM sodium piruvate, 0.5 mM 2-mer-
captoethanol, 0.1mg/mL streptomycin, 100 U/mL penicil-
lin and 10% v/v heat-inactivated fetal calf serum. Cells
were seeded in 48-well microtitre plates (4105 cells/
well), and stimulated with 1 mg/mL phorbol 12-myristate
13-acetate (PMA) (Sigma-Aldrich, St Louis, MO, USA) and
2.5 mg/mL ionomycin or a mixture of house dust mite
(HDM) Dermatophagoides pteronyssinus (Der p 1) (100 ng/
mL) and Dermatophagoides farinae (Der f 1) (100 ng/mL).
Incubation occurred at 37 1C in a humidified atmosphere
with 5% CO2 for 24 h (PMA1ionomycin) or 7 days (Der p 1
and Der f 1 media mixture). Controls with non-stimulated
cells were incubated under the same conditions for both
periods. After incubation, cells were re-suspended in
culture medium, placed into identified microtubes and
centrifuged at 1000 g for 5min at 4 1C. Each pellet was
re-suspended in RNA laters (Sigma-Aldrich), and stored
at 20 1C.
Extraction of RNA and reverse transcription
Total mRNA was isolated from the cell pellets using the
GenElutes Mammalian Total RNA kit (Sigma-Aldrich),
according to the manufacturer’s instructions, and quanti-
fied using a UV1101 – Biotech spectrophotometer (WPA,
Cambridge, UK). A260–A280 ratios were also measured
and only samples with A260/A280 ratios between 1.9 and
2.1 were considered. One microgram of RNA from each
sample was reverse transcribed to cDNA using the High
Capacity cDNA Archive Kit (Applied Biosystems, Foster
City, CA, USA) reagent, according to the manufacturer’s
instructions.
Quantitative polymerase chain reaction for cytotoxic T-
lymphocyte-associated antigen-4, Foxp3, interferon-g,
transforming growth factor-b and interleukin-10
Real-time PCR was performed in a 7500 Fast Real Time
system (Applied Biosystems) using Taqman PCR Universal
Master Mixs, primers and Taqman probes for CTLA-4,
Foxp3, IFN-g, TGF-b and IL-10 genes provided by Applied
Biosystems, according to the manufacturer’s instructions.
Real-time PCR reactions were performed in duplicate for
each gene and for the housekeeping gene (b-actin), as well
as negative control reactions (without any cDNA added)
with each primer and a probe. Reaction mixtures
were subjected to 40 reaction cycles. Fluorescence
detection and normalization during the PCR reaction was
controlled using the ABI SDS v2.3 software. For each
individual gene, the respective comparative threshold
cycle (CT) was calculated and the relative expression
of the gene was normalized to the corresponding b-actin
mRNA level. The mRNA relative expression level for
each gene was determined using the 2DDCT formula
according to the CT method described by Livak and
Schmittgen [28]. Differences between the gene expression
in the stimulated cultures and the gene expression in the
respective non-stimulated cultures were presented as
DDCT [29].
Statistical analysis
Depending on the distributions of the results, values were
either reported as meanSEM or median and interquartile
range (P25;P75), and were presented as box and whiskers-
plots with outliers. Statistical data analysis was performed
using the SPSS software (Statistical Package for the Social
Sciences), version 15.0 for Windows. Flow cytometric
data, as well as mRNA expression data, were statistically
compared between healthy and wheezy children using the
Student’s t-test or the Mann–Whitney U-test (whenever
variable distributions were not normal). Subgroup com-
parisons to determine statistically significant differences
were performed by either ANOVA I (variance analysis) or the
Kruskal–Wallis test, whenever ANOVA I could not be used.
The least significant difference (LSD) test was applied to
ranks when significant statistical differences were de-
tected between subgroups. The associations between la-
boratory parameters and recurrent wheeze were also
investigated using univariate and multiple linear regres-
sion analyses. Statistical significance was defined by a
P-value ofo0.05.
Results
Characteristics of the study participants
Eighty children participated in this study and were classi-
fied as mentioned above. In the index group, 50 wheezy
young children, who were steroid naı¨ve, were further
divided into two at-risk groups for developing subsequent
asthma: low risk (n= 33) and high risk (n= 17). The control
group comprised 30 age-matched healthy children who
had no prior history of lower respiratory illness or wheeze.
Immunological assessments using the flow cytometer
were made using blood samples obtained from all chil-
dren, together with determination of cytokine expression.
At the time of immunological measurement, infants were
free of respiratory symptoms or illness for at least 3 weeks.
No significant differences were found between children
participating in the study regarding age, sex and smoke
c 2009 The Authors
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exposure during pregnancy (Table 1). Among the wheezy
children, 13 (26%) had a parental history of asthma, three
(6%) had a personal history of eczema, seven (14%) had a
personal history of AR, 21 (42%) had wheezing without
colds and 14 (28%) had peripheral blood eosinophilia
44%. In the high-risk group, 13 (76%) had a parental
history of asthma, three (18%) had a personal history of
eczema, five (29%) had a personal history of rhinitis, 12
(71%) had wheezing without colds and nine (53%) had
peripheral blood eosinophilia 44%. In the low-risk
group, two (6%) had a personal history of rhinitis, nine
(27%) had wheezing without colds and five (15%) had
peripheral blood eosinophilia44%.
CD41 CD251 T cells – characterization of different subsets
among study groups
The following populations within the study groups were
compared and evaluated: CD41CD251 T cells,
CD41CD25high T cells, CD41CD251CTLA-41 T cells,
CD41CD251GITR1 T cells and CD41CD25highFoxp31
T cells. When comparing children with wheeze with
healthy controls, we found significantly lower
CD41CD25high T absolute cell counts in the wheezy group
(24887 vs. 29698 cells/mL, P = 0.03). These children
also had lower absolute and percentage values for
CD41CD251CTLA-41. However, as shown in Table 2, no
significant differences between the two groups were
found either for the percentage of CD41CD25high-expres-
sing cells or for the other cell populations studied (percen-
tage or absolute values). When data were evaluated for the
three different groups (high risk, low risk and healthy
children), absolute numbers of CD41CD251 (527147 vs.






Male, n (%) 32 (64%) 22 (73%) 0.4
Maternal smoking during
pregnancy, n (%)
14 (28%) 5 (17%) 0.2
Age, weeksw 63.2 (16.6) 66.2 (16.7) 0.4
Results expressed as n (%) – w2 test.
wResults expressed as mean (SD) – Student’s t-test.
Table 2. Results for CD41 T cells subsets (flow cytometry), and for relative quantification of mRNA expression after PMA stimulation (24 h incubation)
and HDM extract stimulation (7 days incubation), in wheezy and healthy children




506 (162) 563 (147) 0.1
% CD41CD251

15.9 (3.3) 15.2 (2.4) 0.4
Abs CD41CD25high

248 (87) 296 (98) 0.03
% CD41CD25high
w
7.5 (6.4; 8.7) 7.4 (6.8; 9) 0.4
Abs CD41CD251 CTLA-41
w
24 (13; 43) 96 (35; 178) 0.0001
% CD41CD251 CTLA-41
w
0.8 (0.5; 1.3) 2.8 (1.0; 4.3) 0.0001
Abs CD41CD251 GITR1
w
12 (3; 30) 20 (7; 38) 0.2
% CD41CD251 GITR1
w
0.3 (0.1; 0.9) 0.5 (0.2; 0.8) 0.3
Abs CD41CD25high Foxp31

145 (98) 166 (69) 0.4
% CD41CD25high Foxp31

4.4 (2.7) 4.5 (1.6) 0.9
mRNA expression
CTLA-4w (PMA 24h) 3.2 (2.5; 4.2) 4.7 (1.5; 5.8) 0.03
CTLA-4w (HDM 7 days) 0.4 (1.2; 0.5) 0.3 (0.5; 1.2) 0.03
Foxp3w (PMA 24h) 0.4 (0.2; 1.1) 1.6 (0.3; 2.1) 0.02
Foxp3 (HDM 7 days) 0.02 (0.2) 0.06 (0.3) 0.9
IFN-gw (PMA 24 h) 8.1 (5.4; 9.7) 4.8 (0.3; 9.5) 0.09
IFN-gw (HDM 7 days) 0.5 (1.6; 0.3) 0.2 (0.7; 1.7) 0.04
IL-10 (PMA 24h) 1.7 (0.5) 1.8 (0.5) 0.9
IL-10w (HDM 7 days) 0.2 (0.8; 1.0) 0.3 (1.3; 1) 0.9
TGF-bw (PMA 24 h) 1.7 (0.9; 2.3) 1.9 (0.3; 2.3) 0.7
TGF-bw (HDM 7 days) 0.05 (0.5; 0.6) 0.2 (0.5; 0.7) 0.9
Results were calculated as described in ‘‘Methods,’’ with gene expression values corresponding to the expression of a defined gene in a stimulated
cell culture compared with non-stimulated control cells (negative and positive values indicate, respectively, decreased and increased expression
of the gene).
Results expressed as mean (SD), Student’s t-test.
wResults expressed as median (P25;P75), Mann–Whitney test.
CTLA-4; cytotoxic T-lymphocyte-associated antigen-4; HDM, house dust mite; PMA, phorbol 12-myristate 13-acetate.
c 2009 The Authors
Journal compilation c 2009 Blackwell Publishing Ltd, Clinical & Experimental Allergy, 39 : 1160–1169
Regulatory cells and cytokine pattern in wheezing children 1163
425129 cells/mL, P= 0.004) and CD41CD25high T cells
(29698 vs. 21070 cells/mL, P= 0.002) were significantly
higher in the healthy group compared with the high-risk
group. However, no significant differences were observed
between healthy and low-risk children. CD41CD251 and
CD41CD25high percentage values presented no significant
differences between the three groups. Children from the
high-risk group also exhibited lower absolute counts
for both CD41CD251 and CD41CD25high populations
when compared with the low-risk group (Table 3 and
Fig. 1). Different findings were obtained with the
CD41CD251CTLA-41 population: both the high- and the
low-risk wheezy children had lower values for percentage
and absolute numbers in comparison with healthy chil-
dren. However, between high- and low-risk groups, no
significant differences in the absolute and percentage
values of the CD41CD251CTLA-41 population were
found. For the other populations studied (Tables 2 and 3),
no statistically significant differences were found between
groups although there was a tendency towards higher
values in healthy children.
Cytokines, cytotoxic T-lymphocyte-associated antigen-4
and Foxp3 expression post-phorbol 12-myristate 13-
acetate stimulation
After the 24-h incubation period for cell cultures stimu-
lated with PMA, the values for the healthy group showed
Table 3. Results for CD41 T cells subsets (flow cytometry), and for relative quantification of mRNA expression after PMA stimulation (24 h incubation)
and HDM extract stimulation (7 days incubation), in HC (healthy controls), LRG (low-risk wheezy children) and HRG (high-risk wheezy children)
Abs – absolute count values




425 (129) 544 (163) 527 (147)
% CD41CD251

15.9 (4.9) 15.9 (3.2) 15.2 (2.4)
Abs CD41CD25high
w
210 (70) 266 (89) 296 (98)
% CD41CD25high
z
7.31 (6.2; 8.4) 7.7 (6.4; 8.7) 7.4 (6.8; 9)
Abs CD41CD251 CTLA-41
zw
24 (11; 43) 24 (14; 51) 96 (35; 178)
% CD41CD251 CTLA-41
zw
0.88 (0.6; 1.3) 0.76 (0.4; 1.6) 2.8 (1.0; 4.3)
Abs CD41CD251 GITR1
z
14 (5; 32) 11 (3; 25) 20 (7; 38)
% CD41CD251 GITR1
z
0.40 (0.2; 1) 0.25 (0.1; 0.8) 0.5 (0.2; 0.8)
Abs CD41CD25high Foxp31

121 (95) 156 (99) 164 (69)
% CD41CD25high Foxp31

4.3 (3.1) 4.4 (2.6) 4.5 (1.6)
mRNA expression
CTLA-4z (PMA 24 h) 2.9 (2.3; 4.2) 3.3 (2.8; 4.2) 4.7 (1.5; 5.8)
CTLA-4z (HDM 7 days)w 0.7 (1.3; 0.4) 0.01 (0.8; 0.6) 0.3 (0.5; 1.2)
Foxp3z (PMA 24h) 0.4 (0.8; 0.7) 0.4 (0.2; 1.1) 1.6 (0.3; 2.1)
Foxp3 (HDM 7 days) 0.3 (0.5) 0.2 (0.3) 0.06 (0.3)
IFN-gz (PMA 24h) 9.5 (6.2; 10.5) 7.6 (5,4; 8.7) 4.8 (0.3; 9.5)
IFN-gz (HDM 7 days)w 1.3 (1.7; 0.9) 0.1 (1.4; 0.8) 0.2 (0.7; 1.7)
IL-10 (PMA 24h) 1.5 (1.1) 1.9 (0.6) 1.8 (0.5)
IL-10z (HDM 7 days) 0.3 (0.9; 1.1) 0.3 (0.9; 1,1) 0.3 (1.3; 1)
TGF-bz (PMA 24h) 1.6 (0.9; 2,2) 1.7 (0.9; 2.3) 1.9 (0.3; 2.3)
TGF-bz (HDM 7 days) 0.2 (0.2; 0.7) 0.2 (1.1; 0.5) 0.2 (0.5; 0.7)
Values were calculated as described in ‘‘Methods,’’ with gene expression values corresponding to the expression of a defined gene in a stimulated cell
culture compared with non-stimulated control cells (negative and positive values indicate, respectively, decreased and increased expression of the gene).
Results expressed as mean (SD). Group comparisons with ANOVA.
wGroup comparisons for all parameters with statistically significant differences between groups are shown in Fig. 1a–f.
zResults expressed as median (P25;P75). Group comparisons with Kruskall–Wallis test.
CTLA-4, cytotoxic T-lymphocyte-associated antigen-4; HDM, house dust mite; PMA, phorbol 12-myristate 13-acetate.
Fig. 1. (a)–(f). Group comparisons for parameters with statistically significant differences between groups: (a) CD41CD251 absolute values, (b)
CD41CD25high absolute values, (c) CD41CD251CTLA-41 absolute values, (d) CD41CD251CTLA-41 percentage values, (e) CTLA-4 relative expression,‰
(f) INF-g relative expression.‰ The median is represented by the black bar; the lower and upper bounds of the box represent the 25th and 75th
percentile; the whiskers represent the 5th and 95th percentiles; and outliers are represented as circles/asterisks outside the whiskers. HC, healthy
children; LRC, low risk for asthma wheezing children; HRC, high risk for asthma wheezing children. ‰Values were calculated as described in ‘‘Methods’’
and correspond to the gene in an house dust mite-stimulated cell culture compared with non-stimulated control cells (negative and positive values
indicate, respectively, decreased and increased expression of the gene). CTLA, cytotoxic T-lymphocyte-associated antigen-4.
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significantly higher CTLA-4 and Foxp3 mRNA expression
compared with those obtained in the wheezy group (Table
2). For IFN-g, IL-10 and TGF-b, no significant differences
were found in mRNA expression (Table 2). When results
were analysed, separating high- and low-risk groups, no
significant differences were found between the three
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Cytokines, cytotoxic T-lymphocyte-associated antigen-4
and Foxp3 expression post-house dust mite extract
stimulation
After the incubation period of 7 days with HDM extracts, a
significantly higher expression of CTLA-4 and IFN-g was
observed in healthy children compared with wheezy
children (Table 2). However, considering high and low
asthma risk groups, only the high-risk group maintained
this tendency for significantly lower expression levels in
both CTLA-4 and IFN-g, when compared with healthy
controls (Table 3). The low-risk group presented no
significant difference in expression levels compared with
the healthy controls. However, when compared with the
high-risk group, they presented higher IFN-g mRNA
expression values as shown in Table 3 and Fig. 1f. In the
evaluation of the cytokine and Foxp3 expression, only
IFN-g was significantly different between the low- and
high-risk groups.
Associations between recurrent wheeze and flow cytometry
parameters and messenger RNA expression
After adjusting for possible confounding factors identified
by univariate analysis (i.e. sex, age and smoke exposure),
the associations between flow cytometry parameters and
recurrent wheeze, with a high and a low risk for asthma,
were evaluated using multiple linear regression. No sig-
nificant correlations were found for the parameters that
had statistically significant differences between groups
(percentage values of CD41CD251 CTLA-41, and absolute
values of CD41CD251CTLA-41, CD41CD251 and
CD41CD25high). In the same way, associations between
mRNA expression and recurrent wheeze, with a high and a
low risk for asthma, were evaluated using multiple linear
regression analysis, after adjusting for the same possible
confounding factors identified using univariate analysis.
No statistically significant associations were found for the
parameters evaluated (CTLA-4 and IFN-g mRNA expres-
sion).
Discussion
The main aim of this study was to characterize and
establish the differences in the immunological status of
children with recurrent wheeze (with high- or low-risk
factors for asthma) and healthy children. No significant
differences were found between children participating in
the study regarding sex, age and smoke exposure (during
pregnancy), which suggests that none of these factors
affected the results.
Several studies have investigated the CD41CD251 T cell
population, reporting its role in regulating the immune
response. Regulatory pathways of CD41CD251 T cells
include mechanisms like cell-contact dependent suppres-
sion, in which CTLA-4 molecules are involved [17, 18]. An
increase in Treg has been associated with an increased
expression of CTLA-4molecules, which seem to have an
important role in the suppressor activity of those cells [20,
21]. In our study, wheezy children were not only found to
have lower absolute counts of CD41CD25high T cells but
also a reduction in CD41CD251CTLA-41 T cells when
compared with healthy children. Both low- and high-risk
groups presented a reduced CD41CD251CTLA-41 popu-
lation (absolute and percentage values), corroborating the
defective expression of regulatory molecules in wheezy
children, suggesting that diminished CTLA-4 surface ex-
pression may be associated with recurrent wheeze. It
should also be noted that the wheezy group had low
counts of CD41CD25high T cells, which have been reported
to have a primordial function as regulatory cells [22]. The
finding of a reduction in CD41CD251 and CD41CD25high
T cells (absolute counts) among the high-risk wheezy
young children is consistent with that observed by Hadde-
land et al. [30], who described impaired capacity of
producing Treg in neonates with a hereditary allergy risk
when compared with a control group. Interestingly, lower
absolute values for CD41CD251 and CD41CD25high T cells
were also found in the high-risk group compared with the
low-risk group. No significant differences were found
when comparing the three groups for the percentage
values of these populations. We speculate that, in young
children, considering the limitations in sample quantities
available for each subject (specifically due to age), com-
bined with the normal low frequencies of the cells studied
(rare events), the evaluation of absolute values should be
preferred in detriment of percentages. Similarly, other
authors found no significant statistical differences be-
tween percentage values for CD41CD251 [31] and
CD41CD25high [27, 32] in asthmatic children. In an animal
model of asthma, Tregs have been shown to accumulate in
the airway during the development of allergic inflamma-
tion [33]. Nevertheless, Hartl et al. [27] studied Treg
in BAL, reporting impaired numbers and function of
CD41 CD25high T cells in children with asthma compared
with healthy children. In the present study, we were not
able to measure CD41CD25high T cells in the airway;
therefore, we cannot speculate whether the results found
in peripheral blood could constitute, or not, the mirror
of the airway.
At first glance, the differences reported for
CD41CD25high cells between groups should be similar to
Foxp3 expression in these cells, as published literature has
suggested that most CD41CD25high Treg express Foxp3
[34, 35], which might even differentiate them from acti-
vated cells [24]. Surprisingly, in this study, the significant
differences found between the wheezy and the control
groups in CD41CD25high absolute numbers were not ob-
served in either percentage or absolute values of Foxp3
expression in the CD41CD25high population. Even though
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several authors have described CD25 and Foxp3 as Treg
markers [36–38], activated and regulatory CD41 T cells
might have an overlapping expression of CD25 and,
recently, Morgan et al. [39] reported Foxp3 expression in
activated cells, after induction. In agreement, previous
reports postulate that Foxp3 expression might be inter-
mittent in Treg, and even induced, in order to promote the
development of regulatory phenotypes [40]. Further work
is required to clarify the associations between Foxp3,
CD41CD25high and the regulatory activity of T cells.
Regarding PBMC stimulation, unspecific and allergenic
stimuli presented distinctive results. In the current study,
after an HDM–specific stimulation, decreased mRNA ex-
pression of CTLA-4 mRNA was observed in wheezy
children compared with healthy children, and also in the
high-risk group compared with the healthy group. No
differences were reported for Foxp3 expression after HDM
stimulation. On the other hand, after PMA stimulation, the
reduction in CTLA-4 and Foxp3 mRNA expression found
in the wheezy group was only statistically significant
when compared with the values in healthy children; no
significant differences for these parameters were observed
when comparing the high- and low-risk wheezy sub-
groups separately with the healthy group. These data are
suggestive that recurrent wheeze, independent of the risk
for asthma, may be associated with impaired expression of
these molecules after innate stimulation. Shaub et al. [41]
presented similar results, reporting no significant differ-
ences for Foxp3 and CTLA-4 expression, when comparing
neonates from atopic and non-atopic mothers. In our
study, mRNA expression of regulating cytokines IL-10
and TGF-b showed no significant differences between
groups for either innate (PMA) or allergenic (HDM)
stimuli. TGF-b has been reported to be a key element in
Foxp3 expression [42]. Indeed, particularly in the HDM
stimulus, the absence of significant differences occurred
for both Foxp3 and TGF-b. However, this absence of a
significant difference in TGF-b also supports the Foxp3
findings in mRNA expression. Conflicting results have
been reported in the literature regarding the findings of
IL-10. After peptidoglican stimulation, Schaub et al.
[41]reported no significant differences between offspring
from atopic and non-atopic mothers. Other studies also
reported no difference in IL-10 mRNA expression between
children with a high risk and a low risk for atopic diseases,
only defined by a family history of allergy, after cord
blood cell stimulation with mitogenic agents [43], and no
differences in IL-10 mRNA expression between asthmatic
children and a control group [44]. Nevertheless, Treg
producing IL-10 and Th2 cells seem to be unbalanced in
atopic/allergic diseases [45].
Although IFN-g showed a lower expression in the entire
wheezing population after HDM stimulation, it was the
only parameter to discriminate between wheezy children
with a high and a low risk for asthma. Some studies
reported an association between decreased IFN-g expres-
sion and atopic diseases [9, 46, 47]. In the Tucson study
[48], a decreased production of IFN-g in stimulated PBMC
observed in infants at birth and at three months has been
associated with a high risk for recurrent wheeze in the first
year of life. Van der Velden et al. [49] reported no
significant differences in IFN-g production after unspeci-
fic stimulation (as was similarly observed in the present
study) but only after an allergenic stimulus in children
with a high risk for atopic diseases, defined by a family
history of atopy. These authors related the increased
production of Th2 cytokines, after cell stimulation with
allergen, to an impaired production of IFN-g in high-risk
children, corroborating IFN-g as a potent Th2 response
inhibitor.
The main strength of this study is that, to our knowl-
edge, this is the first report that has compared immunolo-
gical measurements, in young children with recurrent
wheeze, according to their risk for asthma, using the
predictive index published by Castro-Rodriguez et al. [5].
One of the limitations of this study was the absence of
measurements of cytokines from the culture supernatants.
These would have allowed the evaluation of cytokine
expression on the protein level but these measurements
were not included in this protocol as it would have
prolonged the analysis process and increased the costs.
Moreover, mRNA expression after cell stimulation was
also applied to the evaluation of other markers (Foxp3,
CTLA-4) that cannot be measured in supernatants. An-
other limitation is the lack of assessment of CD103/CD127
surface expression, which was recently described to dif-
ferentiate Treg cell subsets [50–52].
In summary, the findings from this study suggested that
children with recurrent wheeze appear to have lower
absolute numbers of Treg populations (CD41CD25high
and CD41CD251CTLA-41), and also a lower expression
of CTLA-4 and IFN-g (after HDM stimulation) than
healthy controls. However, when using the clinical index
published by Castro-Rodriguez et al. [5], the only para-
meters that could distinguish a high risk from a low risk
for asthma wheezing children were lower absolute num-
bers of CD41CD251 and CD41CD25high T cells and lower
expression of IFN-g after HDM stimulation in the high-
risk group.
Although the use of immunological parameters in the
clinical management of young children with recurrent
wheeze remains controversial, the findings from the
current study may provide support for the use of such
parameters in this clinical group of young children, in
combination with additional clinical aspects for both
diagnostic and therapeutic procedures. Indeed, a preco-
cious identification of children with a high risk for asthma
will be fundamental for starting treatments before any
airway damage or irreversible airway remodelling. Long-
itudinal follow-up studies may provide for the importance
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of these immunological evaluations as surrogate predictor
factors for asthma in early life.
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